Time of progression to osteopenia/osteoporosis in chronically HIV-infected patients: screening DXA scan

PLoS One. 2012;7(10):e46031. doi: 10.1371/journal.pone.0046031. Epub 2012 Oct 8.

Abstract

Background: Algorithms for bone mineral density (BMD) management in HIV-infected patients are lacking. Our objective was to assess how often a dual-energy x-ray absorptiometry (DXA) scan should be performed by assessing time of progression to osteopenia/osteoporosis.

Methods: All DXA scans performed between 2000 and 2009 from HIV-infected patients with at least two DXA were included. Time to an event (osteopenia and osteoporosis) was assessed using the Kaplan-Meier method. Strata (tertiles) were defined using baseline minimum T scores. Differences between strata in time to an event were compared with the log-rank test.

Results: Of 391 patients (1,639 DXAs), 49.6% had osteopenia and 21.7% osteoporosis at their first DXA scan. Of the 112 (28.6%) with normal BMD, 35.7% progressed to osteopenia; median progression time was 6.7 years. These patients were stratified: "low-risk" (baseline minimum T score >-0.2 SD), "middle-risk" (between -0.2 and -0.6 SD), and "high-risk" (from -0.6 to -1 SD); median progression time to osteopenia was 8.7, >7.2, and 1.7 years, respectively (p<0.0001). Of patients with osteopenia, 23.7% progressed to osteoporosis; median progression time was >8.5 years. Progression time was >8.2 years in "low-risk" tertile (T score between -1.1 and -1.6 SD), >8.5 years in "middle-risk" (between -1.6 and -2), and 3.2 years in "high-risk" (from -2 to -2.4) (p<0.0001).

Conclusions: Our results may help to define the BMD testing interval. The lowest T score tertiles would suggest recommending a subsequent DXA in 1-2 years; in the highest tertiles, ≥6 years. Early intervention in patients with bone demineralization could reduce fracture-related morbidity/mortality.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Absorptiometry, Photon / methods
  • Adult
  • Bone Demineralization, Pathologic / complications*
  • Bone Demineralization, Pathologic / diagnosis
  • Bone Density
  • Bone Diseases, Metabolic / complications*
  • Bone Diseases, Metabolic / diagnosis
  • Chronic Disease
  • Disease Progression
  • Female
  • Follow-Up Studies
  • HIV Infections / complications*
  • Humans
  • Kaplan-Meier Estimate
  • Longitudinal Studies
  • Male
  • Mass Screening / methods
  • Osteoporosis / complications*
  • Osteoporosis / diagnosis
  • Retrospective Studies
  • Time Factors

Grants and funding

This work was supported in part by a grant from the Spanish Ministry of Education and Science [Grant number MTM2008-06747-C02-00]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.